Strategy

We ensure our inter-departmental communication is to the point by having specific and detailed systems in place

Medicair’s strategy comprises of a commitment to growth and a focus on innovation. We invest more than 7% of our turnover on research to reinforce our competitive advantages and continuously upgrade our services and capabilities.

We ensure our inter-departmental communication is to the point by having specific and detailed systems in place. We believe in efficiency and teamwork and we offer continuous training to our employees to facilitate their growth and empowerment.

Aside from investing to our people and our research department, we also invest in new equipment and machinery and we review our manufacturing processes constantly to keep up to date with the latest advancements in the pharmaceuticals industry.

It is of the utmost importance for us to tie our success with the betterment of the quality of life of the people who use our products, therefore our main strategy has been and will remain to focus on innovation that benefits everyone.

New Products

Responding to the emerging market needs

As our company grows, our product range expands. Responding to the emerging market needs, we are currently working on a bevy of projects with many products at the final stages of development. As soon as the final product analysis take place, we will be able to proceed with registrations.

wdt_ID Molecule Form Strength
1 CHOLECALCIFEROL (VITAMIN D3) Hard Liquid Capsule 10000 IU, 25000 IU
2 CHOLECALCIFEROL (VITAMIN D3) Oral Solution Monodose 25000 IU, 50000 IU, 100000 IU
3 CHOLECALCIFEROL (VITAMIN D3) Oral Solution Drops 10000 IU PER ml
4 PREDNISOLONE Oral Solution 1 mg/ml 60 ml – 120 ml, 5 mg/ml 30 ml – 60 ml, 10 mg/ml 30 ml – 60 ml
5 DEXAMETHASONE Oral Solution 10 mg/5 ml - 50 ml, 20 mg/5 ml - 30 ml
14 PARACETAMOL Oral Solution 500 mg/ 5 ml, 150 ml
15 MAGNESIUM OXIDE Effervescent Tablet 498 mg
16 CAPSAICIN Cream 0.08%
17 GALANTAMINE Oral Solution 4 mg/1 ml, 100 ml
18 ROSUVASTATIN CALCIUM Tablet 5 mg, 10 mg, 20 mg
19 EZETIMIBE Tablet 10 mg
20 EZETIMIBE + ROSUVASTATIN Tablet 10mg + 5mg, 10mg + 10mg, 10mg + 20mg, 10mg + 40mg
21 METFORMIN Syrop 850 mg/5 ml, 150 ml - 300ml
Privacy Overview
Medicair-Logo

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.